When the goal is harmonized patient results, the correct procedure for EQA samples is to run them identically to patient specimens, then mathematically reverse the internal calibration adjustment before submitting the numerical value.
Your laboratory operates a network of instruments where custom calibration factors are deliberately applied to align patient results across sites. For External Quality Assessment (EQA) or proficiency testing (PT), you must continue to process the sample through this harmonized workflow. However, just before reporting the result to the EQA provider, you strip out that custom adjustment factor – restoring the value to the manufacturer’s original calibration baseline. This single step keeps your EQA evaluation valid, your peer group comparison meaningful, and your practices fully compliant with regulatory requirements.
The core principle is: test EQA samples like a patient, report them like a native instrument. By mathematically removing your bespoke harmonization offset only at the reporting stage, you satisfy the twin demands of identical sample processing and accurate peer-group benchmarking.
Why Harmonization Adjustments Exist in the First Place
The Practical Need for Inter‑Site Alignment
Multi‑site diagnostic networks often face small but clinically meaningful biases between identical instrument models. A calibration adjustment factor – applied as a slope, intercept, or offset correction – aligns the patient results from satellite laboratories with the main hub.
This harmonization directly improves continuity of care. A patient’s troponin or HbA1c must look the same regardless of which laboratory in the network performed the test.
The Hidden Dual‑Reporting Challenge
The same correction that makes patient results portable would distort your EQA evaluation if left in place. EQA programs assign you to a peer group defined by the instrument manufacturer and reagent lot. Your performance is judged against the mean of that group, which operates on the manufacturer’s calibration. If you submit a result carrying your internal offset, you will deviate artificially from the peer mean – not because of an analytical error, but because of your deliberate network adjustment.
The Correct Protocol for EQA Samples
Step 1: Run the Sample Like a Routine Patient
From the moment the EQA material arrives to the moment the result is generated, the sample must travel through the exact same workflow as a clinical specimen. Any pre‑analytical handling, dilution, internal correction, or middleware flagging that applies to patient samples must also apply to the EQA sample. This non‑negotiable rule guarantees that you are evaluating the system you actually use for patient care.
Step 2: Mathematically Reverse the Adjustment Before Submission
Once the instrument outputs a harmonized value (patient‑equivalent), you calculate backwards to remove your custom factor. For example, if your adjustment multiplies patient results by a factor of 1.05 to align with the main site, you would divide the EQA result by 1.05 before electronically submitting it to the provider. This reversal is a simple mathematical step performed on the final reported number – no new calibrator, no separate run, no altered instrument settings.
What You Must Not Do
Recalibrating the instrument specifically for EQA testing is prohibited. The most common temptation is to load a fresh set of calibrators, revert to manufacturer settings, and run the EQA sample in a “clean” state just for the proficiency event. This violates the requirement that EQA samples be treated identically to patient samples. Doing so would mask calibration drift or matrix effects that real patients would encounter – providing a false picture of your laboratory’s true performance.
Why This Protocol Matters for Your Quality System
Preserving a Valid Peer‑Group Comparison
When you mathematically remove your harmonization factor, your result now sits squarely on the manufacturer’s calibration baseline. This allows the EQA provider to compare it fairly against instruments of the same make and model. Any deviation from the peer mean will then reflect true analytical error (e.g., instrument drift, reagent lot variation, operator technique) rather than your intentional, clinically justified adjustment.
Meeting Regulatory Standards by Design
Accreditation bodies require that proficiency samples are indistinguishable from patient samples in handling. By keeping your workflow identical and only applying a post‑analytical mathematical correction, you demonstrate compliance elegantly. You are not special‑casing EQA; you are simply normalizing the final number to the reference frame that the external assessor expects.
Distinguishing IQC from EQA in a Harmonized Environment
Internal Quality Control (IQC) materials run daily and alert you to immediate system instability. In a harmonized network, you may even choose to keep the adjustment factor active when evaluating your IQC, using in‑house targets that reflect your aligned patient scale. EQA serves a complementary but different role: it benchmarks your raw analytical performance against the outside world. Separating these purposes through the EQA reversal step keeps both functions intact without mixing their signals.
Understanding the Trade‑offs and Pitfalls
The Risk of Double‑Adjusting or Forgetting
The most common mistake is submitting the harmonized result without reversal. The consequence is a sudden, unexplained EQA failure that can trigger an investigation – and potentially jeopardize your accreditation status. The opposite error – applying the reversal to patient results – would undo the harmonization you designed to protect continuity of care. Clear documentation, locked electronic reporting interfaces, or a dedicated EQA data‑handling workflow are essential to prevent missteps.
When the Adjustment Itself Is Complex
Some harmonization protocols use patient‑specific weighting or non‑linear functions that are difficult to reverse mathematically. In such cases, you must validate an exact inverse function. If the transformation is un‑invertible, consult with your EQA provider about reporting under a custom peer group or using an alternative assessment approach. However, for the vast majority of multi‑site alignments – simple slopes, intercepts, or lot‑based offsets – reversal is straightforward and safe.
The Temptation to Optimize EQA at the Expense of Patient Care
Separating the EQA result from the patient workflow can lead a laboratory to “chase the peer mean” rather than tune the assay for clinical needs. Remember: the harmonization adjustment exists because it improves patient care across your network. The EQA reversal is merely a reporting convention to keep your external evaluation honest; it must never drive you to alter the clinically validated harmonization itself.
Making the Right Choice for Your Quality‑Assurance Goal
Apply these targeted recommendations to protect both your network harmonization and your EQA standing:
- If your primary focus is regulatory compliance: Run EQA samples exactly as patient samples. Then, before any data leaves your laboratory, mathematically reverse the calibration adjustment factor. This satisfies the identical‑handling rule and the peer‑group baseline requirement in one simple step.
- If your primary focus is accurate peer‑group performance tracking: Use the reversed result to monitor genuine analytical drift. Any shift from the previous EQA cycle, once the harmonization factor is removed, points to a true instrument or reagent issue that needs immediate attention.
- If your primary focus is patient‑result portability across your network: Protect the harmonization factor at all costs. Do not let EQA reporting procedures – which are a transient, administrative step – distort the clinical alignment that your clinicians rely on every day.
- If your primary focus is audit‑proof documentation: Create a clear standard operating procedure that logs both the original harmonized EQA value and the reversed submitted value. This transparency will satisfy any inspector and will also provide a valuable troubleshooting trail if an EQA result ever falls outside acceptable limits.
By keeping your EQA sample processing identical and your result reporting mathematically normalized, you turn a potential conflict into a clean, defensible quality‑assurance routine.
Summary Table:
| Workflow Phase | Recommended Action | Core Objective & Benefit |
|---|---|---|
| Sample Processing | Analyze EQA samples identically to routine patient specimens. | Ensures true operational handling and system performance are evaluated. |
| Post-Analysis | Mathematically reverse internal harmonization factors before submission. | Restores value to manufacturer baseline for valid peer-group comparison. |
| Data Reporting | Submit the un-adjusted numerical value to the EQA provider. | Prevents artificial deviations, false failures, and accreditation risks. |
| Documentation | Log both internal harmonized and reported reversed values. | Establishes an audit-proof trail for regulatory inspections and troubleshooting. |
Need expert support in optimizing assay performance, harmonization, or assay development? CamelBio provides diagnostic manufacturers, clinical labs, and research institutes with one-stop access to premium IVD raw materials, technical services, and consulting—covering every stage from concept to clinic. Contact us today to streamline your diagnostic workflows and elevate your laboratory's precision!